This is a draft version - Page is not published

Financing, Equity Capital Markets

Point Biopharmaa Inc.

09/22
|
$139.4 Million
Piper Sandler served as bookrunner for POINT Biopharmaa Global, Inc. on its follow on offering
Sub-Type
CMFO
Sector
Healthcare
Sub-Sector
Biopharma

Related Transactions

All Transactions
$50.00
HQC
Clearsense
Minority Capital Raise
Sole Placement Agent
$110.50
Paragon 28, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$287.50
Pliant Therapeutics, Inc.
Follow-On Offering
Active Bookrunner
$97.70
CymaBay Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$125.00
Fulcrum Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$154.40
Skyward
Skyward Specialty Insurance
Initial Public Offering
Passive Bookrunner
AspenAerogels
Aspen Aerogels, Inc.
At The Market Offering
Active Bookrunner
$172.50
Cactus Wellheard, LLC
Follow-On Offering
Passive Bookrunner
$65.00
Redwood Trust
Preferred Stock
Active Bookrunner
$14.80
Pedcor Financial, LLC
Subordinated Notes
Sole Placement Agent
$60.30
National Multifamily Real Estate Operator
Senior Notes
Sole Placement Agent
$6.00
Pedcor Financial, LLC
Preferred Stock
Sole Placement Agent
$50.00
Knighthead
Knighthead Annuity & Life Insurance Company
Senior Notes
Sole Placement Agent
$20.00
Kingstone
Kingstone Companies, Inc.
Private Placement of Senior Notes
Financial Advisor
$63.20
Waypoint
Waypoint Residential, LLC
Senior Notes
Sole Placement Agent
$30.00
Kingstone
Kingstone Companies, Inc.
Debt Refinancing & Exchange Offer of Senior Notes
Financial Advisor

© 2023 Piper Sandler Companies. Since 1895. All rights reserved.